undamentalytics Newsletter
Sign in

Guardian Pharmacy Services, Inc. income statement

In fiscal 2025, Guardian Pharmacy Services, Inc. reported revenue of $1.45bn, up 17.9% on the year before, operating income of $72.7m (a 5.0% margin) and net income of $49.2m. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2024Dec 20242025Dec 2025LTMJun 2026
Revenue1,2281,4491,463
Cost of revenue9841,1561,147
Gross profit244293317
Selling, general and administrative307220231
Operating income−637385
Interest expense311
Income before tax−667396
Income tax52429
Net income−1104966
EBITDA−4395109

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ADUS vs GRDNGRDN vs PIIIGRDN vs HQY

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Guardian Pharmacy Services, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Guardian Pharmacy Services, Inc.